AD/PD™ 2025 Junior Faculty Awards
Application is closed.
For every edition of the AD/PD™ International Conference the Organizing Committee recognizes the top junior and trainee abstract presenters with Junior Faculty Awards*.
Recipients of this award will give an oral presentation on their research during the Conference.
The application deadline for the 2025 Junior Faculty Awards was September 25, 2024.
Application is through the abstract submission system.
*Eligible candidates for the Junior Faculty Awards are graduate students (PhD, MD) or junior scientists up to five years after the doctorate degree (PhD, MD).
Meet the AD/PD™ 2025 Junior Faculty Award Winners
Kyusik Ahn
South KoreaAbstract: BYPASSING BLOOD-BRAIN BARRIER (BBB): THE ROLE OF VISCERAL SENSORY NERVES (VSN) IN THE TRANSMISSION OF PATHOGENIC MOLECULES FROM GUT TO BRAIN IN ALZHEIMER’S DISEASE (AD)
Dario Bachmann
SwitzerlandAbstract: INFLUENCE OF WHITE MATTER HYPERINTENSITIES ON THE PREDICTIVE PERFORMANCE OF ALZHEIMER’S AND NEURODEGENERATION BIOMARKERS FOR COGNITIVE DECLINE IN NON-DEMENTED ADULTS
Shreyasee Das
BelgiumAbstract: PLASMA SNAP25 HAS DIAGNOSTIC AND PROGNOSTIC POTENTIAL IN PRE-CLINICAL ALZHEIMER’S DISEASE: A MULTI- COHORT STUDY
Hannah de Bruin
GermanyAbstract: CONNECTIVITY AS A UNIVERSAL PREDICTOR OF TAU SPREADING IN ATYPICAL ALZHEIMER’S DISEASE
Evangelos Galaris
SwedenAbstract: IDENTIFYING SPATIAL PATTERNS OF WHITE MATTER HYPERINTENSITIES USING SPECTRAL CLUSTERING
Alexandra Gogola
United StatesAbstract: TAU IMAGING THRESHOLDS AS PREDICTORS OF TAU ACCUMULATION AND COGNITIVE DECLINE IN NON-DEMENTED INDIVIDUALS IN THE NIA-AA MULTILEVEL TAU STAGING
Julia Greenland
United KingdomAbstract: AZATHIOPRINE FOR PARKINSON’S DISEASE: A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (AZA-PD)
Nanna Møller Jensen
DenmarkAbstract: THE LRRK2-LEWY BODY CONUNDRUM: DEMONSTRATION OF WIDESPREAD ALPHA-SYNUCLEIN AGGREGATE PATHOLOGY IN LEWY BODY-NEGATIVE LRRK2-MUTANT CASES
Charmaine Lim
AustriaAbstract: MODELLING PRODROMAL PARKINSON’S DISEASE: PROGRESSION OF ALPHA-SYNUCLEINOPATHY FROM HUMAN-DERIVED LEWY BODY INOCULATIONS IN THE MOUSE OLFACTORY BULB
Arthur Macedo
CanadaAbstract: THE SPATIAL SPREAD OF TAUOPATHY PRECEDES THE INCREASE IN TAU-PET SUVR IN ALZHEIMER’S DISEASE
Johannes Michaelian
AustraliaAbstract: FRAILTY, SARCOPENIA, BLOOD-BASED BIOMARKERS OF NEURODEGENERATION AND INCIDENT DEMENTIA: A 17-YEAR LONGITUDINAL POPULATION STUDY
Milan Nemy
SwedenAbstract: VALIDATION OF CHOLINERGIC WHITE MATTER BIOMARKERS IN ALZHEIMER’S DISEASE AND DEMENTIA WITH LEWY BODIES
Maria Tzousi Papavergi
The NetherlandsAbstract: DECIPHERING THE ROLE OF COMPLEMENT C3 IN ANTI-AMYLOID ANTIBODY-INDUCED ARIA
Carmen Peña Bautista
SwedenAbstract: PLASMA AND MRI BIOMARKERS IN DEMENTIA WITH LEWY BODIES AND ALZHEIMER’S DISEASE
Sherilyn Junelle Recinto
CanadaAbstract: UNVEILING PINK1-MEDIATED REGULATION OF MTDNA-DEPENDENT CGAS/STING-NF-KB SIGNALING IN MYELOID CELLS FOR THERAPEUTICALLY TARGETING THE INITIATING MECHANISMS OF PARKINSON’S DISEASE
Sebastian N. Roemer-Cassiano
GermanyAbstract: AMYLOID-ASSOCIATED HYPERCONNECTIVITY DRIVES TAU SPREADING ACROSS CONNECTED BRAIN REGIONS IN ALZHEIMER’S DISEASE
Susan Rohde
NetherlandsAbstract: HIPPOCAMPAL AMYLOID-BETA AND TAU DISTRIBUTIONS DIFFERENTIALLY AFFECT COGNITION IN CENTENARIANS
Hayley Shanks
CanadaAbstract: CHOLINERGIC BASAL FOREBRAIN DEGENERATION PREDICTS INDIVIDUALIZED TRAJECTORIES OF CORTICAL TAU PATHOLOGY AND COGNITIVE DECLINE
Sho Shimohama
JapanAbstract: THE ICELANDIC MUTATION (APP-A673T) IS PROTECTIVE AGAINST AMYLOID PATHOLOGY IN VIVO
Lynn van Olst
United StatesAbstract: ASPATIAL TRANSCRIPTOMICS REVEALS MICROGLIAL MECHANISMS OF AMYLOID-BETA CLEARANCE IN IMMUNIZED ALZHEIMER’S DISEASE PATIENTS